A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer

Oren Levy, W. Nathaniel Brennen, Edward Han, David Marc Rosen, Juliet Musabeyezu, Helia Safaee, Sudhir Ranganath, Jessica Ngai, Martina Heinelt, Yuka Milton, Hao Wang, Sachin H. Bhagchandani, Nitin Joshi, Neil Bhowmick, Samuel R. Denmeade, John T. Isaacs, Jeffrey M. Karp